Brief: Lee's Pharmaceutical Says Obtained Drug Marketing Authorisation Of Azilsartan Tablets From NMPA On Sept 20
29/09/2022 15:32
Sept 29 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* ON SEPT 20, OBTAINED DRUG MARKETING AUTHORISATION OF
AZILSARTAN
TABLETS FROM NMPA
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA